Form4insider filings, from the source

SEC Form 4 · accession 0001144204-18-019461

Cytosorbents Corp · CTSO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kathleen P. Bloch
Officer — Chief Financial Officer
Period of report
Feb 21, 2018
Accepted (ET)
Apr 5, 2018 · 7:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 21, 2018M10,000$2.90A268,870D
Common StockF2,F3Feb 21, 2018S10,000$8.00D258,870D
Common StockF4holding———9,000ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)$2.90Feb 21, 2018M10,000DMay 29, 2015May 29, 2023Common Stock10,00010,000D

Explanation of responses